
TY  - JOUR
TI  - Issue Information
JO  - International Journal of Laboratory Hematology
JA  - Int. Jnl. Lab. Hem.
VL  - 38
IS  - S2
SN  - 1751-5521
UR  - https://doi.org/10.1111/ijlh.12568
DO  - doi:10.1111/ijlh.12568
SP  - i
EP  - xi
PY  - 2016
ER  - 

TY  - JOUR
TI  - Lunchtime Posters
JO  - Colorectal Disease
JA  - Colorectal Dis
VL  - 18
IS  - S1
SN  - 1462-8910
UR  - https://doi.org/10.1111/codi.13444
DO  - doi:10.1111/codi.13444
SP  - 27
EP  - 43
PY  - 2016
ER  - 

TY  - JOUR
TI  - Abtracts
JO  - Journal of Medical Primatology
JA  - J Med Primatol
VL  - 45
IS  - 5
SN  - 0047-2565
UR  - https://doi.org/10.1111/jmp.12245
DO  - doi:10.1111/jmp.12245
SP  - 222
EP  - 274
PY  - 2016
ER  - 

TY  - JOUR
TI  - Oral Communications
JO  - International Journal of Andrology
VL  - 33
IS  - s1
SN  - 0105-6263
UR  - https://doi.org/10.1111/j.1365-2605.2010.01106.x
DO  - doi:10.1111/j.1365-2605.2010.01106.x
SP  - 39
EP  - 63
PY  - 2010
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - Journal of Neurochemistry
JA  - J. Neurochem.
VL  - 142
IS  - S2
SN  - 0022-3042
UR  - https://doi.org/10.1111/jnc.13925
DO  - doi:10.1111/jnc.13925
SP  - 188
EP  - 225
PY  - 2017
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - Clinical Endocrinology
JA  - Clin Endocrinol
VL  - 86
IS  - S1
SN  - 0300-0664
UR  - https://doi.org/10.1111/cen.13259
DO  - doi:10.1111/cen.13259
SP  - 1
EP  - 68
PY  - 2017
ER  - 

TY  - JOUR
AU  - Sarnat, Harvey B.
AU  - Yu, Weiming
TI  - Maturation and Dysgenesis of the Human Olfactory Bulb
JO  - Brain Pathology
JA  - Brain Pathology
VL  - 26
IS  - 3
SN  - 1015-6305
UR  - https://doi.org/10.1111/bpa.12275
DO  - doi:10.1111/bpa.12275
SP  - 301
EP  - 318
KW  - calretinin
KW  - dysgenesis
KW  - fetal development
KW  - hemimegalencephaly
KW  - hydrocephalus
KW  - NeuN
KW  - olfactory bulb
KW  - olfactory tract
KW  - progenitor cells
KW  - synaptophysin
PY  - 2016
AB  - Abstract The olfactory bulb with its unique architecture was studied for neuronal maturation in human fetuses. Neuroblasts stream into the olfactory bulb from the rostral telencephalon and secondarily migrate radially. The transitory olfactory ventricular recess regresses postnatally. Olfactory is the only sensory system without thalamic projections but incorporates intrinsic thalamic equivalents. The bulb is a repository of progenitor cells. Maturation of the bulb and tract was studied in 18 normal human fetuses of 16?41 weeks gestation; mid-gestational twins with hydrocephalus; 7 arrhinencephaly/holoprosencephaly; 2 olfactory dysgeneses. Multiple immunoreactivities were performed. Synaptophysin around mitral neurons, in a few synaptic glomeruli and concentric lamination of the outer granular layer, was seen at 16 weeks. Outer granular neurons exhibited NeuN at 16 weeks, only 2/3 were reactive at term. Concentric alternating sheets of granular neurons and their dendrodendritic synapses are seen during maturation. Calretinin reactivity is seen in neurons and neurites, primary olfactory nerve axons, periglomerular cells and neuroepithelial cells surrounding the ventricular recess; reactivity occurs later in synaptic glomeruli than with synaptophysin; not all glomeruli are strongly reactive even at term. Nestin- and vimentin-reactive bipolar progenitor cells were demonstrated at all ages and extend into the olfactory tract. Myelin is demonstrated by Luxol fast blue (LFB) only postnatally. In hydrocephalus, the olfactory recess is dilated. Mitral cell dispersion, disrupted glomeruli, heterotopia and maturational delay are seen in some dysgeneses. Malformations exhibit unique findings. Fusion of hypoplastic bulbs can occur. Abnormal architecture is seen in hemimegalencephaly. More documentation of olfactory dysgenesis is needed in other major brain malformations.
ER  - 

TY  - JOUR
TI  - European Society for Veterinary Clinical Pathology (ESVCP) 13th Annual Congress
JO  - Veterinary Clinical Pathology
JA  - Vet Clin Pathol
VL  - 41
IS  - 1
SN  - 0275-6382
UR  - https://doi.org/10.1111/j.1939-165X.2011.00375.x
DO  - doi:10.1111/j.1939-165X.2011.00375.x
SP  - E1
EP  - E16
PY  - 2012
ER  - 

TY  - JOUR
TI  - The 2015 Annual Meeting of the International Genetic Epidemiology Society
JO  - Genetic Epidemiology
JA  - Genet. Epidemiol.
VL  - 39
IS  - 7
SN  - 0741-0395
UR  - https://doi.org/10.1002/gepi.21916
DO  - doi:10.1002/gepi.21916
SP  - 529
EP  - 599
PY  - 2015
ER  - 

AU  - Oleinikov, Andrew V.
AU  - Gray, Matthew D.
C7  - pp. 1-40
TI  - RNA Interference: The Next Gene-Targeted Medicine
UR  - https://doi.org/10.1002/9780470571224.pse324
DO  - doi:10.1002/9780470571224.pse324
SP  - 1-40
KW  - gene expression
KW  - RNA interference
KW  - molecular research
KW  - drug development
PY  - 2015
AB  - Abstract The newest laboratory method for modulating gene expression, RNA interference (RNAi), has gained rapid interest throughout the world of molecular research, and is being actively pursued as the next ?gene-targeted medicine.? RNAi is a process in which double-stranded RNA (dsRNA) directs the specific degradation of a corresponding target mRNA. This article describes the main ideas, approaches, and technological directions that may guide the medical researcher interested in using RNAi methodologies to identify and develop new drug candidates.
ER  - 

TY  - JOUR
TI  - Winter Meeting 2013. Joint Meeting of the Pathological Society of Great Britain & Ireland and the Dutch Pathological Society (NVVP), 8–9 January
JO  - The Journal of Pathology
JA  - J. Pathol.
VL  - 229
IS  - s1
UR  - https://doi.org/10.1002/path.4190
DO  - doi:10.1002/path.4190
SP  - 1
EP  - 31
PY  - 2013
ER  - 

TY  - JOUR
TI  - Poster Sessions
JO  - Pediatric Diabetes
JA  - Pediatric Diabetes
VL  - 15
IS  - s19
UR  - https://doi.org/10.1111/pedi.12194_2
DO  - doi:10.1111/pedi.12194_2
SP  - 49
EP  - 137
PY  - 2014
ER  - 

TY  - JOUR
TI  - BioIron Abstracts
JO  - American Journal of Hematology
JA  - Am. J. Hematol.
VL  - 88
IS  - 5
UR  - https://doi.org/10.1002/ajh.23453
DO  - doi:10.1002/ajh.23453
SP  - E5
EP  - E243
PY  - 2013
ER  - 

TY  - JOUR
TI  - 2017 ACVIM Forum Research Abstract Program
JO  - Journal of Veterinary Internal Medicine
JA  - J Vet Intern Med
VL  - 31
IS  - 4
UR  - https://doi.org/10.1111/jvim.14778
DO  - doi:10.1111/jvim.14778
SP  - 1225
EP  - 1361
PY  - 2017
ER  - 

TY  - JOUR
AU  - LeBleu, Valerie S.
AU  - Neilson, Eric G.
TI  - Origin and functional heterogeneity of fibroblasts
JO  - The FASEB Journal
JA  - The FASEB Journal
VL  - n/a
IS  - n/a
UR  - https://doi.org/10.1096/fj.201903188R
DO  - doi:10.1096/fj.201903188R
KW  - cancer
KW  - endothelial-to-mesenchymal transition
KW  - epithelial-to-mesenchymal transition
KW  - fibroblasts
KW  - fibrosis
KW  - mesenchymal state
AB  - Abstract The inherent plasticity and resiliency of fibroblasts make this cell type a conventional tool for basic research. But where do they come from, are all fibroblasts the same, and how do they function in disease? The first fibroblast lineages in mammalian development emerge from the ooze of primary mesenchyme during gastrulation. They are cells that efficiently create and negotiate the extracellular matrix of the mesoderm in order to migrate and meet their developmental fate. Mature fibroblasts in epithelial tissues live in the interstitial spaces between basement membranes that spatially delimit complex organ structures. While the function of resident fibroblasts in healthy tissues is largely conjecture, the accumulation of fibroblasts in pathologic lesions offers insight into biologic mechanisms that control their function; fibroblasts are poised to coordinate fibrogenesis in tissue injury, neoplasia, and aging. Here, we examine the developmental origin and plasticity of fibroblasts, their molecular and functional definitions, the epigenetic control underlying their identity and activation, and the evolution of their immune regulatory functions. These topics are reviewed through the lens of fate mapping using genetically engineered mouse models and from the perspective of single-cell RNA sequencing. Recent observations suggest dynamic and heterogeneous functions for fibroblasts that underscore their complex molecular signatures and utility in injured tissues.
ER  - 

TY  - JOUR
TI  - Keyword Index
JO  - The FEBS Journal
JA  - FEBS J
VL  - 281
IS  - s1
UR  - https://doi.org/10.1111/febs.12976
DO  - doi:10.1111/febs.12976
SP  - 809
EP  - 823
PY  - 2014
ER  - 

TY  - JOUR
TI  - British Society for Matrix Biology Spring 2006 and Abstracts, Queens College, Cambridge
JO  - International Journal of Experimental Pathology
VL  - 88
IS  - 2
UR  - https://doi.org/10.1111/j.1365-2613.2007.00508.x
DO  - doi:10.1111/j.1365-2613.2007.00508.x
SP  - A1
EP  - A45
PY  - 2007
ER  - 

TY  - JOUR
TI  - Drugs and the Brain
JO  - Basic & Clinical Pharmacology & Toxicology
JA  - Basic Clin Pharmacol Toxicol
VL  - 115
IS  - s1
UR  - https://doi.org/10.1111/bcpt.12259_5
DO  - doi:10.1111/bcpt.12259_5
SP  - 173
EP  - 222
PY  - 2014
ER  - 

TY  - JOUR
TI  - ISLH 2019 Abstracts
JO  - International Journal of Laboratory Hematology
JA  - Int J Lab Hem
VL  - 41
IS  - S2
UR  - https://doi.org/10.1111/ijlh.13105
DO  - doi:10.1111/ijlh.13105
SP  - 1
EP  - 205
PY  - 2019
ER  - 

TY  - JOUR
TI  - Symposia
JO  - The FEBS Journal
VL  - 276
IS  - s1
UR  - https://doi.org/10.1111/j.1742-4658.2009.07046.x
DO  - doi:10.1111/j.1742-4658.2009.07046.x
SP  - 5
EP  - 84
PY  - 2009
ER  - 
